Susana Ortiz-Urda, MD, PhD, MBA

Dermatologist and melanoma specialist

Dr. Susana Ortiz-Urda, co-director of the UCSF Melanoma Center, treats patients with early and advanced melanoma. Her lab has a broad expertise in human models of epithelial neoplasia and melanoma. She studies in depth cancer signaling to identify novel transcripts, their functions and the factors that promote resistance to drugs and/or cancer progression via transcriptome (RNA-Seq) to capture the implicated coding and non-coding elements in this process. These findings might serve as key biomarkers and/or new targets for therapeutics in melanoma.

Ortiz-Urda earned a medical degree and doctorate at the University of Vienna in Austria. She completed a residency in dermatology and a postdoctoral fellowship in epithelial biology, both at Stanford University, followed by a cutaneous oncology fellowship in dermatology at UCSF and an MBA at NYU. She is a member of the American Academy of Dermatology, Austrian Society of Dermatology and Venereology, and Dermatology Foundation. Ortiz-Urda has received several awards, including the Kardinal-Innitzer Award for Outstanding Science in Dermatology and the Unilever Award from the Austrian Society for Dermatology and Venereology. She is an assistant professor of dermatology at UCSF.

Learn more about Ortiz-Urda's research: http://cancer.ucsf.edu/research/ortiz-lab.

  • Hear an interview with Ortiz-Urda, who discusses new medications for the deadliest form of skin cancer.

If you need to make an appointment, click here.

Clinics

Melanoma and Skin Cancer Program
1600 Divisadero St., Third Floor
San Francisco, CA 94115
Phone: (415) 353-9900
Fax: (415) 885-3802

Hours: Monday to Friday, 8 a.m. - 5 p.m.

Conditions & Treatments

Board Certification

Dermatology, American Board of Dermatology

Academic Title

Assistant Professor

More about Susana Ortiz-Urda

Additional Languages

German
Spanish

Education

University of Vienna School of Medicine 1998

Residencies

UCSF Medical Center, Dermatology 2010
Stanford Medical Center, Dermatology 2010

Selected Research and Publications

  1. Posch C, Cholewa BD, Vujic I, Sanlorenzo M, Ma J, Kim ST, Kleffel S, Schatton T, Rappersberger K, Gutteridge R, Ahmad N, Ortiz/Urda S. Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma. J Invest Dermatol. 2015 Oct; 135(10):2475-2483.
  2. Curl P, Vujic I, van 't Veer LJ, Ortiz-Urda S, Kahn JG. Correction: Cost-Effectiveness Of Treatment Strategies for BRAF-Mutated Metastatic Melanoma. PLoS One. 2015; 10(4):e0126988.
  3. Sanlorenzo M, Vujic I, Posch C, Cleaver JE, Quaglino P, Ortiz-Urda S. The risk of melanoma in pilots and cabin crew: UV measurements in flying airplanes. JAMA Dermatol. 2015 Apr; 151(4):450-2.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.